The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review

BACKGROUND: Although acute oxaliplatin-induced neuropathy (OXIPN) is frequently regarded to be transient, recent studies have reported prolongation of infusion times, dose reduction and treatment cessation following the first dose of oxaliplatin in quarter of patients. Acute OXIPN is also a well-est...

Descripción completa

Detalles Bibliográficos
Autores principales: Gebremedhn, Endale Gebreegziabher, Shortland, Peter John, Mahns, David Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897924/
https://www.ncbi.nlm.nih.gov/pubmed/29649985
http://dx.doi.org/10.1186/s12885-018-4185-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897924/
https://www.ncbi.nlm.nih.gov/pubmed/29649985
http://dx.doi.org/10.1186/s12885-018-4185-0

Ejemplares similares